KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Net Income: 2009-2024

Historic Net Income for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$119.0 million.

  • Nektar Therapeutics' Net Income rose 5.58% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.4 million, marking a year-over-year increase of 32.63%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.90% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Net Income is -$119.0 million, which was up 56.90% from -$276.1 million recorded in FY2023.
  • Over the past 5 years, Nektar Therapeutics' Net Income peaked at -$119.0 million during FY2024, and registered a low of -$525.1 million during FY2021.
  • Its 3-year average for Net Income is -$256.7 million, with a median of -$276.1 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first decreased by 18.15% in 2021, then spiked by 56.90% in 2024.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Net Income stood at -$444.4 million in 2020, then dropped by 18.15% to -$525.1 million in 2021, then climbed by 28.56% to -$375.1 million in 2022, then rose by 26.41% to -$276.1 million in 2023, then spiked by 56.90% to -$119.0 million in 2024.